AUTHOR AND EDITOR INFORMATION

Section 1 of 9  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• References

INTRODUCTION

Section 2 of 9  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• References

Background

In 1971, George Wells first described this syndrome as a recurrent granulomatous dermatitis with eosinophilia. Wells and Smith renamed it eosinophilic cellulitis in 1979.

Eosinophilic cellulitis (Wells syndrome) is an uncommon condition of unknown etiology. The presentation usually involves a mildly pruritic or tender cellulitislike eruption with typical histologic features characterized by edema, flame figures, and a marked infiltrate of eosinophils in the dermis. Papular and nodular eruptions at the clinical presentation have also been reported. The condition can recur and may be preceded by a pruritic papular eruption. Although Wells syndrome is usually sporadic, some familial cases have been reported.

One study showed the successive occurrence of vasculitis, Wells syndrome, and Sweet syndrome in a patient. This finding suggests that an overlap between these diseases exists (Consigny, 2001). Another report describes a dominant syndrome consisting of eosinophilic cellulitis, mental retardation, and abnormal body habitus in one family (Davis, 1998).

Pathophysiology

The etiology is unknown. At least some cases may represent hypersensitivity to an arthropod bite or sting. A dermal infiltrate of histiocytes, eosinophils, and eosinophilic granules occurs between collagen bundles, which forms the classic flame figures. The eosinophilic infiltrate is almost always restricted to the epidermis and the dermis, but it has also been found in the subcutaneous tissue and the underlying muscle. The location of the infiltrate is correlated with the different clinical features.

In one study, immunophenotyping of peripheral T cells revealed an increased proportion of CD3⁺ and CD4⁺T cells (Plotz, 2000). These lymphocytes spontaneously release significant amounts of interleukin 5 (IL-5); this finding suggests that activated T cells may be involved in the pathogenesis of blood and tissue eosinophilia. The eosinophils then degranulate in the dermis, causing edema and inflammation.

With immunofluorescent stains, eosinophil major basic protein is identified in the granules of the flame figures. On electron microscopy, the collagen fibers are intact; this finding suggests that an initial degeneration of collagen is not a factor in initiating the formation of flame figures.

Eosinophilic cellulitis may be due to drugs, various infections, and, possibly, nonhematological malignancies as trigger events (Hirsch, 2005). Wells syndrome has also been reported to occur in patients with hypereosinophilic syndrome and Churg-Strauss syndrome.

Frequency

United States

Wells syndrome is rare.

International

Only about 80 cases have been reported internationally, including domestically.

Mortality/Morbidity

Although long-term sequelae usually do not result, reticular pigmentation and scarring alopecia may occur.

Race

Wells syndrome can occur in persons of any race.

Sex

No sexual predilection is reported.

Age

Wells syndrome usually affects adults, but it has been known to occur in children. In one case series of 19 patients, the classic plaque-type presentation was the most common variant found in children, while the annular granuloma–like variant was the most common variant in adults (Caputo, 2006).

CLINICAL

Section 3 of 9  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• References

History

• Usually, the patient complains of pruritus or a burning sensation, which is followed by erythema and edema.
• The clinical presentation can vary widely and may include the following:
• • Annular plaques
  • Vesicles and bullae
  • Urticaria
  • Edema
  • Papules or nodules
• Typically, a tender or mildly pruritic cellulitislike eruption occurs.
• Occasionally, papular and nodular eruptions may be seen first.
• Systemic symptoms, including asthma, arthralgia, and fever, may be evident, although they usually do not occur.

Physical

• The lesions progress over a few days to become large, indurated plaques of edema and erythema, with violaceous edges and no calor.
• The lesions may last for several weeks, but they gradually darken from bright red to slate blue.
• Complete resolution with no scarring is typical, although scarring alopecia may occur.
• The plaques can occur anywhere on the skin, and they may be solitary or multiple.
• Plaques on the affected areas are known to recur, and vesiculobullae may develop over the surface.
• The clinical features seem to depend on the location of the infiltrates in the dermis. This observation suggests that a spectrum of eosinophilic dermatoses occurs in Wells syndrome.

Causes

• The etiology is unknown.
• Wells syndrome is usually sporadic, but some familial cases have been described.
• Suggested precipitating factors include the following:
• • Arthropod bites
  • Cutaneous viral infections
  • Cutaneous parasitic infestations, including toxocariasis, ascariasis, and onchocerciasis
  • Leukemia
  • Myeloproliferative disorders
  • Atopic dermatitis
  • Fungal infections
  • Hypersensitivity reactions to medications

DIFFERENTIALS

Section 4 of 9  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• References

Other Problems to be Considered

Toxocariasis

WORKUP

Section 5 of 9  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• References

Lab Studies

• Peripheral blood and bone marrow eosinophilia are usually present.
• In peripheral blood, an increase in eosinophil cation protein (ECP) and IL-5 levels can be detected. Of note, the levels of ECP and IL-5 seem to be correlated with the severity of the disease.

Procedures

• Eosinophilic cellulitis is usually diagnosed on the basis of the characteristic histopathologic findings in a skin biopsy specimen.

Histologic Findings

Skin biopsy specimens show a dermal infiltrate of eosinophils, histiocytes, and eosinophil debris between collagen bundles that forms flame figures. During the acute early phase, the dense infiltrate of degranulating eosinophils is usually located in the epidermis and the dermis, although it occasionally extends into the subcutaneous tissue and the underlying muscle.

Vesiculation can occur. The blisters contain eosinophils and are predominately subepidermal and, occasionally, multiloculated and spongiotic. The location of the infiltrate is correlated with the different clinical features.

After weeks, the flame figures are seen, along with a palisade of histiocytes and giant cells around some collagen fibers. With immunofluorescent stains, eosinophil major basic protein is identified in the granules of the flame figures. On electron microscopy, the collagen fibers are intact; this finding suggests that an initial degeneration of collagen is not a factor in initiating the formation of flame figures.

Although the histopathologic findings of eosinophilia, histiocytes, and flame figures are characteristic of Wells syndrome, they are also found in other conditions, including bullous pemphigoid, eczema, tinea infection, and insect bites.

TREATMENT

Section 6 of 9  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• References

Medical Care

• Numerous treatment options include the use of topical corticosteroids, griseofulvin, H1 antihistamines, cyclosporine, dapsone, and systemic corticosteroids.
• Systemic corticosteroids are the most effective treatment, but they may lead to corticosteroid dependence.

MEDICATION

Section 7 of 9  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• References

The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Drug Category: Antifungal

Mechanism of action usually involves inhibiting pathways (enzymes, substrates, transport) necessary for sterol/cell membrane synthesis or altering the permeability of the cell membrane (polyenes) of the fungal cell.

Drug Category: Antibiotics

Therapy must cover all likely pathogens in the context of this clinical setting.

Drug Category: Immunosuppressants

These agents inhibit key factors in the immune system responsible for immune reactions.

Drug Category: H1 receptor antagonists

These agents act by competitive inhibition of histamine at the H1 receptor. This mediates the wheal and flare reactions, bronchial constriction, mucous secretion, smooth muscle contraction, edema, hypotension, CNS depression, and cardiac arrhythmias.

FOLLOW-UP

Section 8 of 9  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• References

Complications

• Rarely, Wells syndrome is associated with systemic disease, even some life-threatening diseases, including leukemia and lymphoma. However, at this point, determining if these are coincidental findings or real associations is impossible.

Prognosis

• The prognosis for patients with eosinophilic cellulitis is excellent.
• Eosinophilic cellulitis tends to resolve in weeks or months, usually without scarring. It occasionally recurs, and in these recurrent cases, it can take years to ultimately resolve.

REFERENCES

Section 9 of 9

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• References

• Aberer W, Konrad K, Wolff K. Wells'' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol. Jan 1988;18(1 Pt 1):105-14. [Medline].
• Anderson CR, Jenkins D, Tron V, Prendiville JS. Wells'' syndrome in childhood: case report and review of the literature. J Am Acad Dermatol. Nov 1995;33(5 Pt 2):857-64. [Medline].
• Brehmer-Andersson E, Kaaman T, Skog E, Frithz A. The histopathogenesis of the flame figure in Wells'' syndrome based on five cases. Acta Derm Venereol. 1986;66(3):213-9. [Medline].
• Brown J, Schwartz RA. Wells' syndrome (eosinophilic cellulitis). Cesko-Slovenska Dermatol. 2002;77:261-263.
• Caputo R, Marzano AV, Vezzoli P, Lunardon L. Wells syndrome in adults and children: a report of 19 cases. Arch Dermatol. Sep 2006;142(9):1157-61. [Medline].
• Consigny S, Courville P, Young P, et al. [Histological and clinical forms of the eosinophilic cellulitis]. Ann Dermatol Venereol. Mar 2001;128(3 Pt 1):213-6. [Medline].
• Davis MD, Brown AC, Blackston RD, et al. Familial eosinophilic cellulitis, dysmorphic habitus, and mental retardation. J Am Acad Dermatol. Jun 1998;38(6 Pt 1):919-28. [Medline].
• Espana A, Sanz ML, Sola J, Gil P. Wells'' syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin- 5. Br J Dermatol. Jan 1999;140(1):127-30. [Medline].
• Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med. Jan 4 2005;142(1):47-55. [Medline].
• Fisher GB, Greer KE, Cooper PH. Eosinophilic cellulitis (Wells'' syndrome). Int J Dermatol. Mar 1985;24(2):101-7. [Medline].
• Ghislain PD, Van Eeckhout P. Eosinophilic cellulitis of papulonodular presentation (Wells' syndrome). J Eur Acad Dermatol Venereol. Mar 2005;19(2):226-7. [Medline].
• Herr H, Koh JK. Eosinophilic cellulitis (Wells'' syndrome) successfully treated with low- dose cyclosporine. J Korean Med Sci. Oct 2001;16(5):664-8. [Medline].
• Hirsch K, Ludwig RJ, Wolter M, et al. Eosinophilic cellulitis (Wells' syndrome) associated with colon carcinoma. J Dtsch Dermatol Ges. Jul 2005;3(7):530-1. [Medline].
• Holme SA, McHenry P. Nodular presentation of eosinophilic cellulitis (Wells'' syndrome). Clin Exp Dermatol. Nov 2001;26(8):677-9. [Medline].
• Hurni MA, Gerbig AW, Braathen LR, Hunziker T. Toxocariasis and Wells'' syndrome: a causal relationship?. Dermatology. 1997;195(4):325-8. [Medline].
• Kaufmann D, Pichler W, Beer JH. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne. Arch Intern Med. Sep 12 1994;154(17):1983-4. [Medline].
• Leiferman KM, Peters MS. Reflections on eosinophils and flame figures: where there's smoke there's not necessarily Wells syndrome. Arch Dermatol. Sep 2006;142(9):1215-8. [Medline].
• Moossavi M, Mehregan DR. Wells'' syndrome: a clinical and histopathologic review of seven cases. Int J Dermatol. Jan 2003;42(1):62-7. [Medline].
• Mutasim DF, Cooper CH. A case of Wells' syndrome in a patient with lymphocytic lymphoma. Geriatr Dermatol. 1996;4(1):11-14.
• Newton JA, Greaves MW. Eosinophilic cellulitis (Well''s syndrome) with florid histological changes. Clin Exp Dermatol. Sep 1988;13(5):318-20. [Medline].
• Nielsen T, Schmidt H, Sogaard H. Eosinophilic cellulitis. (Well''s syndrome) in a child. Arch Dermatol. Jul 1981;117(7):427-9. [Medline].
• Odia SG, Purschel W, Worret WI, Rakoski J. Hypereosinophilic cellulitis(Wells' syndrome) resembling urticaria. Acta Derm Venerol (Ljubljana). 1994;6:193-195.
• Peters MS, Schroeter AL, Gleich GJ. Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells'' syndrome. Br J Dermatol. Aug 1983;109(2):141-8. [Medline].
• Plotz SG, Abeck D, Behrendt H, et al. [Eosinophilic cellulitis (Wells syndrome)]. Hautarzt. Mar 2000;51(3):182-6. [Medline].
• Spigel GT, Winkelmann RK. Wells'' syndrome. Recurrent granulomatous dermatitis with eosinophilia. Arch Dermatol. May 1979;115(5):611-3. [Medline].
• Stern JB, Sobel HJ, Rotchford JP. Wells'' syndrome: is there collagen damage in the flame figures?. J Cutan Pathol. Dec 1984;11(6):501-5. [Medline].
• Tsuda S, Tanaka K, Miyasato M, et al. Eosinophilic cellulitis (Wells'' syndrome) associated with ascariasis. Acta Derm Venereol. Jul 1994;74(4):292-4. [Medline].
• Wells GC, Smith NP. Eosinophilic cellulitis. Br J Dermatol. Jan 1979;100(1):101-9. [Medline].
• Wells GC. Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc. 1971;57(1):46-56. [Medline].
• van den Hoogenband HM. Eosinophilic cellulitis as a result of onchocerciasis. Clin Exp Dermatol. Jul 1983;8(4):405-8. [Medline].

Article Last Updated: Feb 1, 2007